Panel Discussion: Striking a Balance: Achieving Anticancer Activity without Toxicity

Time: 2:30 pm
day: Day Two


  • Consider how we can investigate toxicity through dosimetry and how this data can be used in regulator submissions
  • Discuss how dosimetry will play a role in taking on new cancer types
  • How can we overcome the lack of clarity around the application and value of